Cooley LLP announced today that it advised the underwriters on Otonomy, Inc.’s $100 million initial public offering. Otonomy is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of diseases and disorders of the ear. The company now trades of The NASDAQ Global Stock Market under the symbol “OTIC.”
J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated acted as joint book-running managers for the offering, Piper Jaffray & Co. acted as lead manager for the offering and Sanford C. Bernstein & Co., LLC acted as co-manager for the offering.
The Cooley corporate and securities team that advised the underwriters was comprised of partners Charlie Kim, Drew Williamson and David Peinsipp and associates Siana Lowrey, Kristin VanderPas, Rebecca Jones and Dani Nazemian. Critical support for the offering was provided by partners Natasha Leskovsek and Wendy Goldstein, special counsel Phil Mitchell and associate Jennifer Shanley (health care and life sciences regulatory); partner Bill Christiansen (intellectual property); partner Renee Deming and special counsel Jeannie Leahy (compensation and benefits); partner Danish Hamid (FCPA/regulatory); and partner Susan Cooper Philpot (tax).
Thus far in 2014, Cooley has advised on 75 public offerings, including 38 completed IPOs.
